Erez Israeli, Dr. Reddy’s Laboratories CEO
Another Indian drug manufacturer hit with a Form 483 over recent observations
Several Indian drug manufacturers have been put under a microscope by the FDA, as major generics manufacturers have been hit in recent months by Form …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
